[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360522-105":59,"doc-detail-360522-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","araticum-annona-crassiflora-seed-extract-as-a-chemopreventive-agent-against-prostate-cancer-activation-of-extrinsic-and-intrinsic-apoptotic-pathways-in-a-preclinical-model","Araticum (Annona crassiflora) seed extract as a chemopreventive agent against prostate cancer - Activation of extrinsic and intrinsic apoptotic pathways in a preclinical model","","Prostate cancer remains a leading malignancy in aging men and requires safer preventive approaches. Annona crassiflora seed extract (ASE) was tested in the TRAMP transgenic mouse model, comparing vehicle-treated controls with ASE at 100 mg/kg from 8–12 to 12–16 weeks. ASE showed good tolerability with no hepatotoxicity, improved prostatic epithelium features, lowered HGPIN incidence in the ASE 12–16 group, reduced androgen receptor expression and localization, and promoted apoptosis via BID/BAD/BAX upregulation, caspase-8/9/3 activation, and BCL-2-family downregulation, supporting a chemopreventive adjuvant potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/araticum-annona-crassiflora-seed-extract-as-a-chemopreventive-agent-against-prostate-cancer-activation-of-extrinsic-and-intrinsic-apoptotic-pathways-in-a-preclinical-model/360522/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/araticum-annona-crassiflora-seed-extract-as-a-chemopreventive-agent-against-prostate-cancer-activation-of-extrinsic-and-intrinsic-apoptotic-pathways-in-a-preclinical-model/360522.png","ImageObject",300,407,{"name":92,"@type":93},"McGucket","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was Annona crassiflora seed extract (ASE) evaluated for prostate cancer chemoprevention?","Question",{"text":112,"@type":113},"ASE was tested in the TRAMP transgenic mouse prostate cancer model with control groups receiving vehicle and ASE-treated groups receiving 100 mg/kg from 8–12 to 12–16 weeks of age.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What evidence indicates ASE was well tolerated and not hepatotoxic?",{"text":117,"@type":113},"Preservation of hepatic histoarchitecture and normal body weight gain in ASE-treated animals demonstrated good tolerability and no hepatotoxic effects.",{"name":119,"@type":110,"acceptedAnswer":120},"Which apoptotic mechanisms were affected by ASE in prostate lesions?",{"text":121,"@type":113},"ASE increased apoptotic activity through upregulation of BID, BAD, and BAX, activation of caspase-8, caspase-9, and caspase-3, and downregulation of BCL-2, BCL-xL, and MCL-1, creating a pro-apoptotic environment.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360522,1790194367,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Journal of Molecular Histology (2026) 57:195  \n[https://doi.org/10.1007/s10735-026-10859-3](https://doi.org/10.1007/s10735-026-10859-3)  \nORIGINAL PAPER  \nAraticum (Annona crassiflora) seed extract as a chemopreventive agent against prostate cancer: activation of extrinsic and intrinsic apoptotic pathways in a preclinical model  \nIara Lopes Lemos1 · Maria Josiane Macedo1 · Felipe Rabelo Santos2 · Bianca Barbosa Rezende2 · Fabio Montico2 · Valeria Helena Alves Cagnon2 · Mario Roberto Marostica Junior1  \nReceived: 5 March 2026 / Accepted: 6 June 2026 / Published online: 13 June 2026 © The Author(s) 2026  \nAbstract  \nProstate cancer (PCa) is among the most frequently diagnosed malignancies in aging men and remains a major public health concern, highlighting the need for effective and safe preventive strategies. Annona crassiflora Mart. seed extract (ASE) was evaluated using the transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Animals were divided into control and ASE-treated groups evaluated from 8–12 to 12–16 weeks of age. Control groups received the vehicle (water containing 10% DMSO), whereas ASE-treated groups received 100 mg/kg body weight of ASE. The preservation of hepatic histoarchitecture and normal body weight gain demonstrated that ASE was well tolerated and did not show hepatotoxic effects. ASE treatment increased the frequency of healthy prostatic epithelium in early prostate lesions (predominantly low-grade prostatic intraepithelial neoplasia (LGPIN)) and late prostate lesions (high-grade prostatic intraepithelial neoplasia (HGPIN) and well-differentiated adenocarcinoma (WDAC)) of PCa. Furthermore, ASE reduced HGPIN incidence in the ASE 12–16 group, showing a lower incidence of WDAC. In addition, ASE reduced androgen receptor (AR) protein levels as well as cytoplasmic and nuclear AR localization in late prostate lesions (HGPIN and WDAC) of PCa. ASE also induced apoptosis through multiple pathways, including upregulation of BID, BAD, and BAX, activation of caspase-8, caspase-9, and caspase-3, and downregulation of BCL-2, BCL-xL, and MCL-1 . Thus, ASE promotes a pro-apoptotic environment unfavorable to tumor survival. Taken together, these results reinforce the potential of ASE to modulate prostatic homeostasis, indicating a promising strategy with chemopreventive effects and potential as an adjuvant therapy against PCa.  \n􀀍 Iara Lopes Lemos[i235286@dac.unicamp.br](i235286@dac.unicamp.br)  \n􀀍 Mario Roberto Marostica Junior [mmarosti@unicamp.br](mmarosti@unicamp.br)  \nFelipe Rabelo Santos  \n[feliperabelosantos50@gmail.com](feliperabelosantos50@gmail.com)[ ](feliperabelosantos50@gmail.com)Bianca Barbosa Rezende [biancabb-r@hotmail.com](biancabb-r@hotmail.com)  \nFabio Montico  \n[montico@unicamp.br](montico@unicamp.br)  \nValeria Helena Alves Cagnon  \n[quitete@unicamp.br](quitete@unicamp.br)  \n1 Faculty of Food Engineering (FEA), Department of Food Science and Nutrition (DECAN), University of Campinas (UNICAMP), Campinas, São Paulo 13083-862, Brazil  \n2 Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, São Paulo 13083‐862, Brazil  \nGraphical Abstract  \nKeywords Natural products · Bioactive compounds · Cancer · TRAMP mice · Cell death  \nAbbreviations  \nABTS 2,2′-Azinobis-(3-ethylbenzothiazoline-6-sulfonic acid)  \nApaf-1 Apoptotic protease activating factor-1  \nAR Androgen receptor  \nASE Annona crassiflora Seed extract BAD BCL2-associated death agonist BAK BCL-2 antagonist killer  \nBAX BCL-2-associated X protein BCL-2 B-cell lymphoma 2  \nBcl-xL B-cell lymphoma-extra-large  \nBID BH3-interacting domain death agonist  \nDHT Dihydrotestosterone DMSO Dimethyl sulfoxide  \nFADD Fas-associated death domain protein  \nFRAP Ferric Reducing Antioxidant Power HGPIN High-grade prostatic intraepithelial neoplasia LGPIN Low-grade prostatic intraepithelial neoplasia MCL-1 Myeloid cell leukemia-1  \nORAC Oxygen Radical Absorbance Capacity PCa Prostate cancer  \nPCNA P","cbCaimhV21MCvvAq","https://ap.wps.com/l/cbCaimhV21MCvvAq","pdf",1956309,17,"English","# Abstract\n## Abbreviations\n# Introduction","[{\"question\":\"How was Annona crassiflora seed extract (ASE) evaluated for prostate cancer chemoprevention?\",\"answer\":\"ASE was tested in the TRAMP transgenic mouse prostate cancer model with control groups receiving vehicle and ASE-treated groups receiving 100 mg/kg from 8–12 to 12–16 weeks of age.\"},{\"question\":\"What evidence indicates ASE was well tolerated and not hepatotoxic?\",\"answer\":\"Preservation of hepatic histoarchitecture and normal body weight gain in ASE-treated animals demonstrated good tolerability and no hepatotoxic effects.\"},{\"question\":\"Which apoptotic mechanisms were affected by ASE in prostate lesions?\",\"answer\":\"ASE increased apoptotic activity through upregulation of BID, BAD, and BAX, activation of caspase-8, caspase-9, and caspase-3, and downregulation of BCL-2, BCL-xL, and MCL-1, creating a pro-apoptotic environment.\"}]","Araticum (Annona crassiflora) seed extract as a chemopreventive agent against prostate cancer - Activation of extrinsic and intrinsic apoptotic pathways in a preclinical model | PDF",1790140367,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba140282b74b157825ef40c1682bc4af.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c855fe5ff092b3e4b6e121866472aeb0.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e30fe484e8da8cd645563ce3664ef02.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66d2ea35dc2bfc2fd394a182ccd89d1c.webp",980,1301]